QGEN: Qiagen NV Company Gross Revenue

qiagen.com - graphic logo of issuer QGEN

Qiagen N.V. is implementing ESG principles by reducing plastic in its test systems and optimizing logistics. The company's sales dynamics illustrate the inflow of revenue from sales, where 2.12 determines this parameter level. The business relies on the sale of closed systems and high-margin reagents. Revenue stability is ensured by a balance between equipment deliveries and the regular sale of consumables for DNA analysis.

QGEN - Qiagen N.V. Company Sales over the range 07/04/2022 - 11/17/2026

Comprehensive metric breakdowns and analytics for Qiagen NV (QGEN)

- current price and projected stock value:
Summary company analysis:QGEN (qiagen.com)
Mass-produced product of Qiagen

Stable demand for DNA and RNA laboratory analysis automation drives the fundamental resilience of Qiagen N.V. (QGEN). The company's sales dynamics reflect genuine market interest in robotic sample preparation systems. This metric aggregates daily cash inflows, allowing for the verification of organic revenue growth. Abnormal stagnation of the line may signal hidden risks. This indicator serves as the basis for calculating the asset's fair market value.

Analysis of competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Revenue and Sales Volume IONS|RGEN (Repligen) - Company Sales Revenue|Company Revenue aviditybiosciences.com RNA|CRISPR (CRSP) - Company Total Revenue|genedx.com - Revenue and Sales Volume|Company Sales Revenue RARE (ultragenyx.com)|BEAM: Revenue and Sales Volume|Sarepta - Company Sales Revenue|TWST (twistbioscience.com) - Revenue and Sales Volume|Company Sales Volume TXG (10x Genomics Corp)|Revenue and Sales Volume NTLA|Revenue and Sales Volume Stoke Therapeutics, Inc. (STOK)|Company Revenue BioLife BLFS|WVE - Company Sales|Maze Therapeutics Corp - Revenue and Sales Volume|Sionna Pharma - Company Total Sales|Prime Medicine (PRME) - Company Revenue|tayshagtx.com (TSHA) - Revenue and Sales Volume|Company Revenue uniQure Corp|MGTX: Company Sales Revenue|Revenue and Sales Volume RGNX|Company Gross Revenue Solid Corp|Revenue and Sales Volume OCGN (ocugen.com)|PACB (Pacific Biosciences) - Company Annual Revenue|Benitec Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Company Revenue|4D Molecular Therapeutics (FDMT) - Revenue and Sales Volume|LXEO (Lexeo Therapeutics, Inc.) - Revenue and Sales Volume|Company Total Revenue korrobio.com KRRO|Company Sales EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Company Sales Volume|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales